|
Video: What is a Stock Split?
|
|
AzurRx BioPharma is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Co. is focused on developing its drug product candidate, MS1819, a yeast derived recombinant lipase for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. Co.'s b-lactamase program focuses on products with an enzymatic combination of bacterial origin for the prevention of hospital-acquired infections and antibiotic-associated diarrhea by resistant bacterial strains induced by parenteral administration of several antibiotic classes. Co.'s compounds in pre-clinical development include: AZX1101 and AZX1103. According to our AZRX split history records, AZRX has had 1 split. | |
|
AZRX (AZRX) has 1 split in our AZRX split history database. The split for AZRX took place on September 13, 2021. This was a 1 for 10 reverse split, meaning for each 10 shares of AZRX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as AZRX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AZRX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AZRX shares, starting with a $10,000 purchase of AZRX, presented on a split-history-adjusted basis factoring in the complete AZRX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/12/2016 |
|
End date: |
09/21/2021 |
|
Start price/share: |
$54.80 |
|
End price/share: |
$3.45 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.70% |
|
Average Annual Total Return: |
-42.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$629.72 |
|
Years: |
4.95 |
|
|
|
Date |
Ratio |
09/13/2021 | 1 for 10 |
|
|